ArticleInternational journal of cancer2019

A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.

Sang-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.